Hyperbaric Therapy + Corticosteroid Combo Aids Sudden Sensorineural Hearing Loss
By Lori Solomon HealthDay Reporter
MONDAY, July 14, 2025 -- Hyperbaric oxygen therapy (HBOT) used in conjunction with corticosteroids aids outcomes for sudden sensorineural hearing loss (SSNHL), according to a study published online June 29 in Clinical Otolaryngology.
Bang-Yan Zhang, M.D., from the Fu Jen Catholic University Hospital in New Taipei City, Taiwan, and colleagues evaluated the efficacy of HBOT as an adjunct to corticosteroids in the treatment of SSNHL. The analysis included 128 patients diagnosed with unilateral SSNHL who received corticosteroids and HBOT. Hearing gains were evaluated using audiometric testing both before and after treatment.
The researchers found that 72.7 percent of patients experienced significant hearing improvement. Early initiation of HBOT within 12.5 days of onset was associated with better hearing outcomes. Results of multivariate analysis and sensitivity testing confirmed that HBOT timing was the most robust predictor of hearing gain, independent of baseline hearing loss severity.
"This study highlights the importance of early HBOT combined with corticosteroids in treating SSNHL. Initiating HBOT within 12.5 days significantly improves hearing outcomes," the authors write. "These findings support HBOT as a valuable adjunctive treatment and underscore the need for standardized treatment protocols."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
FRIDAY, Aug. 8, 2025 -- Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published...
'Heart Age' Often Older Than Chronological Age
FRIDAY, Aug. 8, 2025 -- The Predicting Risk of Cardiovascular Disease Events (PREVENT) equation risk age is older than chronological age on average, with greater discordance for...
Nonlinear Inverse Association Seen for Step Count, Peak Cadence With MACE
THURSDAY, Aug. 7, 2025 -- There are nonlinear, inverse associations for step count and peak cadence with the risk for major adverse cardiovascular events (MACE) among individuals...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.